4
Changes in Ownership
NovaBridge Biosciences Filed Acc 0002089237-26-000008
Chief Medical Officer sold 8,209 shares at $0.71 ($5,828)
- Chief Medical Officer acquired 23,695 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dennis Phillip Andrew Chief Medical Officer | 2026-09-17 | Option exercise | +23,695 | 181,636 | D | ||
| Dennis Phillip Andrew Chief Medical Officer | 2026-09-18 | Sale | −8,209 | $0.71 | $5,828 | 173,427 | D |
| Derivatives | |||||||
| Dennis Phillip Andrew Chief Medical Officer | 2026-09-17 | Option exercise · Restricted Share Units | −10,302 | 72,120 | D | ||
| Open-market sales · 8,209 sh · avg $0.71 · $5,828 | |||||||
Loading xslF345X06/form4-09212026_040901.xml…